Xylem Statistics

Total Valuation

Xylem has a market cap or net worth of GBP 23.99 billion. The enterprise value is 24.90 billion.

Market Cap	23.99B
Enterprise Value	24.90B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Nov 26, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+19.87%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	241.16M

Valuation Ratios

The trailing PE ratio is 38.75.

PE Ratio	38.75
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	47.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.81, with an EV/FCF ratio of 40.31.

EV / Earnings	40.22
EV / Sales	3.64
EV / EBITDA	16.81
EV / EBIT	27.10
EV / FCF	40.31

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.20.

Current Ratio	1.96
Quick Ratio	1.31
Debt / Equity	0.20
Debt / EBITDA	1.15
Debt / FCF	2.54
Interest Coverage	23.10

Financial Efficiency

Return on equity (ROE) is 8.08% and return on invested capital (ROIC) is 5.66%.

Return on Equity (ROE)	8.08%
Return on Assets (ROA)	4.43%
Return on Capital (ROIC)	5.66%
Revenue Per Employee	273,267
Profits Per Employee	26,924
Employee Count	23,000
Asset Turnover	0.53
Inventory Turnover	4.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.52% in the last 52 weeks. The beta is 1.05, so Xylem's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+9.52%
50-Day Moving Average	121.62
200-Day Moving Average	131.22
Relative Strength Index (RSI)	60.45
Average Volume (20 Days)	1,454

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, Xylem had revenue of GBP 6.29 billion and earned 619.26 million in profits. Earnings per share was 2.55.

Revenue	6.29B
Gross Profit	2.32B
Operating Income	844.59M
Pretax Income	687.90M
Net Income	619.26M
EBITDA	1.26B
EBIT	844.59M
Earnings Per Share (EPS)	2.55

Full Income Statement

Balance Sheet

The company has 737.89 million in cash and 1.57 billion in debt, giving a net cash position of -831.16 million.

Cash & Cash Equivalents	737.89M
Total Debt	1.57B
Net Cash	-831.16M
Net Cash Per Share	n/a
Equity (Book Value)	7.91B
Book Value Per Share	32.52
Working Capital	1.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 852.79 million and capital expenditures -235.02 million, giving a free cash flow of 617.77 million.

Operating Cash Flow	852.79M
Capital Expenditures	-235.02M
Free Cash Flow	617.77M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 36.93%, with operating and profit margins of 13.44% and 9.85%.

Gross Margin	36.93%
Operating Margin	13.44%
Pretax Margin	10.94%
Profit Margin	9.85%
EBITDA Margin	20.05%
EBIT Margin	13.44%
FCF Margin	9.83%

Dividends & Yields

This stock pays an annual dividend of 1.13, which amounts to a dividend yield of 0.92%.

Dividend Per Share	1.13
Dividend Yield	0.92%
Dividend Growth (YoY)	6.05%
Years of Dividend Growth	7
Payout Ratio	41.33%
Buyback Yield	-19.87%
Shareholder Yield	-18.94%
Earnings Yield	2.58%
FCF Yield	2.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Xylem has an Altman Z-Score of 4.43.

Altman Z-Score	4.43
Piotroski F-Score	n/a